136 related articles for article (PubMed ID: 20595236)
1. Kif18A is involved in human breast carcinogenesis.
Zhang C; Zhu C; Chen H; Li L; Guo L; Jiang W; Lu SH
Carcinogenesis; 2010 Sep; 31(9):1676-84. PubMed ID: 20595236
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract][Full Text] [Related]
3. Molecular interplay between HURP and Kif18A in mitotic spindle regulation.
Nogales E; Perez-Bertoldi J; Zhao Y; Thawani A; Yildiz A
Res Sq; 2024 May; ():. PubMed ID: 38854046
[TBL] [Abstract][Full Text] [Related]
4. Molecular interplay between HURP and Kif18A in mitotic spindle regulation.
Perez-Bertoldi JM; Zhao Y; Thawani A; Yildiz A; Nogales E
bioRxiv; 2024 Apr; ():. PubMed ID: 38645125
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of the KIF18A motor protein in cancers with chromosomal instability.
Nat Cancer; 2024 Jan; 5(1):10-11. PubMed ID: 38267629
[No Abstract] [Full Text] [Related]
6. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
8. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.
Zou JX; Duan Z; Wang J; Sokolov A; Xu J; Chen CZ; Li JJ; Chen HW
Mol Cancer Res; 2014 Apr; 12(4):539-49. PubMed ID: 24391143
[TBL] [Abstract][Full Text] [Related]
9. Kinesin 18A expression: clinical relevance to colorectal cancer progression.
Nagahara M; Nishida N; Iwatsuki M; Ishimaru S; Mimori K; Tanaka F; Nakagawa T; Sato T; Sugihara K; Hoon DS; Mori M
Int J Cancer; 2011 Dec; 129(11):2543-52. PubMed ID: 21213216
[TBL] [Abstract][Full Text] [Related]
10. Novel KIF18A Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2020 Dec; 11(12):2368-2369. PubMed ID: 33335656
[No Abstract] [Full Text] [Related]
11. Chromosomally unstable tumor cells specifically require KIF18A for proliferation.
Marquis C; Fonseca CL; Queen KA; Wood L; Vandal SE; Malaby HLH; Clayton JE; Stumpff J
Nat Commun; 2021 Feb; 12(1):1213. PubMed ID: 33619254
[TBL] [Abstract][Full Text] [Related]
12. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
13. Kif18A uses a microtubule binding site in the tail for plus-end localization and spindle length regulation.
Weaver LN; Ems-McClung SC; Stout JR; LeBlanc C; Shaw SL; Gardner MK; Walczak CE
Curr Biol; 2011 Sep; 21(17):1500-6. PubMed ID: 21885282
[TBL] [Abstract][Full Text] [Related]
14. KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer.
Qian LX; Cao X; Du MY; Ma CX; Zhu HM; Peng Y; Hu XY; He X; Yin L
Biochem Biophys Res Commun; 2021 Jun; 557():192-198. PubMed ID: 33872988
[TBL] [Abstract][Full Text] [Related]
15. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
16. The role of kinesin KIF18A in the invasion and metastasis of hepatocellular carcinoma.
Luo W; Liao M; Liao Y; Chen X; Huang C; Fan J; Liao W
World J Surg Oncol; 2018 Feb; 16(1):36. PubMed ID: 29466986
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
19. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of KIF18A enhances cell proliferation and predicts poor survival in human clear cell renal carcinoma.
Chen QI; Cao B; Nan N; Wang YU; Zhai XU; Li Y; Chong T
Exp Ther Med; 2016 Jul; 12(1):377-383. PubMed ID: 27347065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
